R&D America’s mental health crisis: Why we need a Moonshot Over the last decade, the United States has invested billions of dollars into cutting edge
Podcasts Sponsored The hidden burden of stigmatised health conditions James Geary, MBA, MHA, who lives with a data analyst Cerebral Palsy, anxiety, and depression shares his story.
News NHSBSA releases latest Medicines Used in Mental Health data Covering October to December 2022, the report recorded 21.7m antidepressant items prescribed.
News Third death reported with a Sarepta gene therapy A third fatality has been recorded among patients receiving treatment with a Sarepta gene therapy, adding to the troubles being faced by the company.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face